Efficacy News and Research

RSS

Dynamics of healthcare-associated SARS-CoV-2 infections revealed with whole genome sequencing

In a recent paper, the researchers study the dynamics of SARS-CoV-2 infections on a geriatric hospital ward by whole genome sequencing.

13 Sep 2021

Guidelines: Summer camp returns to normal during COVID-19

A new report describes measures to ensure that youth activities can continue safely, based on sound epidemiological and infectious disease guidelines.

13 Sep 2021

Artemisia plant extract prevents SARS-CoV-2 replication in vitro

A new study describes the beneficial effect of an extract of Artemisia annua when used to treat cells in culture exposed to SARS-CoV-2.

13 Sep 2021

Study identifies broadly neutralizing antibody panel against SARS-like viruses

A recent study describes 40 broadly neutralizing antibodies from two individuals with a history of COVID-19 who were recently immunized against the virus.

13 Sep 2021

Research supports COVID booster vaccines for those aged 60 and over

Israeli researchers conducted an important study to determine if the Pfizer-BioNTech BNT162b2 vaccine had become less effective in preventing infection.

13 Sep 2021

‘No-touch’ technique to remove leg veins leads to better outcomes after heart bypass surgery

When a modified surgical technique was used to gently remove sections of leg veins used in coronary artery bypass surgery, the grafts were less likely to become blocked and fewer people had a recurrence of heart-related chest pain, according to new research published today in the American Heart Association's flagship journal Circulation.

13 Sep 2021

The comparative effectiveness of neutralizing monoclonal antibodies against SARS-CoV-2

A study investigated the comparative efficacy of neutralizing monoclonal antibodies against SARS-CoV-2.

13 Sep 2021

The rate of vaccine-induced heart inflammation in children

In a paper uploaded to the preprint server medRxiv*, a risk-benefit analysis was undertaken utilizing data collected from VAERS relating to adolescents having received an mRNA vaccine before June 18th 2021.

13 Sep 2021

Elevated levels of serotonin can curb cocaine addiction in mice

Elevated levels of serotonin can prevent the development of compulsive cocaine seeking and addiction in mice, researchers report.

13 Sep 2021

Results from Phase 0/1 trial of ribociclib plus everolimus in patients with high-grade glioma announced

The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, announced results from their Phase 0/1 clinical trial of ribociclib plus everolimus in patients with high-grade glioma (HGG).

13 Sep 2021

Scientists develop a novel and potent SARS-CoV-2 RBD-homodimer vaccine

A recent report published in the journal Cell Discovery has described the immunogenicity and protective efficacy of a novel coronavirus disease 2019 (COVID-19) subunit vaccine candidate. The vaccine induces robust immune responses in rodents and non-human primates and protects the animals against severe disease.

12 Sep 2021

Does Delta increase the risk of hospitalization compared with Alpha?

A team of researchers conducted a cohort study to understand the risk of hospitalization in patients with either the Delta or Alpha variants of SARS-CoV-2.

12 Sep 2021

Neoadjuvant CPA followed by surgical resection and maintenance atezolizumab meets safety criteria

Neoadjuvant cisplatin and pemetrexed plus atezolizumab followed by surgical resection and maintenance atezolizumab met safety criteria, according to research presented today in OA13: Topics in Pleural Mesothelioma at the IASLC 2021 World Conference on Lung Cancer.

12 Sep 2021

Combination of chemotherapy and immune checkpoint inhibitors shows promise in NSCLC patients with untreated brain metastases

Treatment with atezolizumab plus carboplatin and pemetrexed was safe and yielded promising brain progression-free survival in patients with nonsquamous non-small cell lung cancer with untreated and asymptomatic brain metastases.

12 Sep 2021

UGA research offers hope for a viable therapeutic to combat COVID-19

As COVID-19 cases continue to skyrocket across the U.S. and the world, few options are available for treating patients infected with the SARS-CoV-2.

11 Sep 2021

UC San Diego receives $12.25 million NIH grant to improve epilepsy treatment

The National Institutes of Health has awarded a $12.25 million grant to the University of California San Diego to develop and enhance brain-sensing and brain-stimulating platform technologies to enable treatment of drug-resistant epilepsy.

10 Sep 2021

Study identifies FDA-approved drugs that are effective in suppressing SARS-CoV-2 replication

Despite the development of SARS-CoV-2 vaccines, effective therapeutics are needed until worldwide immunity has been achieved.

10 Sep 2021

'Cold' tumors can be turned 'hot' with extremely low doses of radiation, study shows

A Ludwig Cancer Research study conducted in both mice and a small group of patients with advanced cancers has shown that so-called “cold” tumors that are nearly devoid of immune cells—and therefore unresponsive to immunotherapy—can be turned “hot” with extremely low doses of radiation and the rational use of existing therapies.

9 Sep 2021

Study explores the science behind cannabis-based medicinal products in pediatric epilepsies

Following media reports of children with epilepsies reportedly deriving benefits from medical marijuana (or cannabis-based medicinal products) accessed abroad, the UK government allowed clinicians to prescribe these products.

9 Sep 2021

Restoring beneficial gut microbes to enhance the efficacy of cancer immunotherapy

The gut microbiome - the collection of bacteria, viruses, fungi, and other microorganisms that reside in our gastrointestinal tracts - can impact us in a variety of different ways, from our metabolism to our mood.

9 Sep 2021

Efficacy News and Research

Dynamics of healthcare-associated SARS-CoV-2 infections revealed with whole genome sequencing

Guidelines: Summer camp returns to normal during COVID-19

Artemisia plant extract prevents SARS-CoV-2 replication in vitro

Study identifies broadly neutralizing antibody panel against SARS-like viruses

Research supports COVID booster vaccines for those aged 60 and over

‘No-touch’ technique to remove leg veins leads to better outcomes after heart bypass surgery

The comparative effectiveness of neutralizing monoclonal antibodies against SARS-CoV-2

The rate of vaccine-induced heart inflammation in children

Elevated levels of serotonin can curb cocaine addiction in mice

Results from Phase 0/1 trial of ribociclib plus everolimus in patients with high-grade glioma announced

Scientists develop a novel and potent SARS-CoV-2 RBD-homodimer vaccine

Does Delta increase the risk of hospitalization compared with Alpha?

Neoadjuvant CPA followed by surgical resection and maintenance atezolizumab meets safety criteria

Combination of chemotherapy and immune checkpoint inhibitors shows promise in NSCLC patients with untreated brain metastases

UGA research offers hope for a viable therapeutic to combat COVID-19

UC San Diego receives $12.25 million NIH grant to improve epilepsy treatment

Study identifies FDA-approved drugs that are effective in suppressing SARS-CoV-2 replication

'Cold' tumors can be turned 'hot' with extremely low doses of radiation, study shows

Study explores the science behind cannabis-based medicinal products in pediatric epilepsies

Restoring beneficial gut microbes to enhance the efficacy of cancer immunotherapy

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News